What, Why & How

Special Edition: December 2022 – Iowa Insurance Division PBM Rules

On December 5, IPA’s Director of Public Affairs, Seth Brown, and Senior Policy Advisor, Brett Barker, recorded a special podcast episode on the Iowa Insurance Division’s release of the PBM rules following the passage of the PBM bill last session. No CE available.

Episode #41: October 2022 – USP Compounding Standards & Delegation of Technical Functions

Following the October 25 Iowa Board of Pharmacy meeting, IPA staff and Andrew Funk from the Board of Pharmacy discuss the role of the Board and programs offered, updated USP compounding standards, and delegation of technical functions to nurses.

Episode #40: August 2022 – Rulemaking Process, Compounding & IMP3 Program

Following the August 24 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the rulemaking process and how a rule is adopted, as well as the Board’s newly adopted compounding rule. In addition, Becky Carlson speaks on the IMP3 Program and its importance in Iowa.

Episode #39: June 2022 – Updated Security Rules & Statewide Protocol Changes

Following the June 28 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the Board’s updated security and controlled substance accountability rules, as well as changes to the Statewide Protocols for naloxone, immunization and tobacco cessation.

Episode #38: May 2022 – Compounding Pharmacies, Comment Periods & Security Changes

Following the May 3 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the FDA’s memorandum of understanding (MOU) for compounding pharmacies distributing medications interstate, the REMS comment period for opioid analgesics, new BOP security rules and more.

Episode #37: March 2022 – Controlled Substances, Practicing Nurses & Telepharmacy

Following the March 1 Iowa Board of Pharmacy meeting, IPA’s Vice President of Government Affairs, Brett Barker, and Sue Mears from the Board of Pharmacy discuss the Board’s 2022 legislation regarding controlled substances and the authority of nurses practicing under a pharmacist’s order, as well as recent rulemaking and telepharmacy provisions from the Board.

Episode #36: January 2022 – USP Revisions, Telepharmacy Rulemaking & Legislative Session

Following the January 11 Iowa Board of Pharmacy meeting, IPA’s Government Relations team, Damian Thompson and Brett Barker, and Sue Mears from the Board of Pharmacy discuss federal comment periods for USP revisions, the DEA rulemaking regarding telepharmacy and transfer of electronic prescriptions for controlled substances, as well as recent rulemaking from the Board.

Episode #35: November 10 – Telepharmacy, Technicians & Upcoming Legislation

Following the November 10 Iowa Board of Pharmacy meeting, IPA’s Vice President of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss rule changes impacting telepharmacy, technicians, and potential legislation in the 2022 session.